Open Access Research

Predicting necrosis in residual mass analysis after retroperitoneal lymph node dissection: a retrospective study

Eduardo de Paula Miranda1, Daniel Kanda Abe1, Adriano João Nesrallah1, Sabrina Thalita dos Reis1, Alexandre Crippa1, Miguel Srougi2 and Marcos Francisco Dall’Oglio1*

Author Affiliations

1 Division of Urology, University of Sao Paulo Medical School and Cancer Institute of Sao Paulo, ICESP, São Paulo, SP, Brazil

2 Division of Urology, University of São Paulo Medical School, São Paulo, Brazil

For all author emails, please log on.

World Journal of Surgical Oncology 2012, 10:203  doi:10.1186/1477-7819-10-203

Published: 28 September 2012

Abstract

Background

Recent studies have demonstrated that pathological analysis of retroperitoneal residual masses of patients with testicular germ cell tumors revealed findings of necrotic debris or fibrosis in up to 50% of patients. We aimed at pursuing a clinical and pathological review of patients undergoing post chemotherapy retroperitoneal lymph node dissection (PC-RPLND) in order to identify variables that may help predict necrosis in the retroperitoneum.

Methods

We performed a retrospective analysis of all patients who underwent PC-RPLND at the University Hospital of the University of São Paulo and Cancer Institute of Sao Paulo between January 2005 and September 2011. Clinical and pathological data were obtained and consisted basically of: measures of retroperitoneal masses, histology of the orchiectomy specimen, serum tumor marker and retroperitoneal nodal size before and after chemotherapy.

Results

We gathered a total of 32 patients with a mean age of 29.7; pathological analysis in our series demonstrated that 15 (47%) had necrosis in residual retroperitoneal masses, 15 had teratoma (47%) and 2 (6.4%) had viable germ cell tumors (GCT). The mean size of the retroperitoneal mass was 4.94 cm in our sample, without a difference between the groups (P = 0.176). From all studied variables, relative changes in retroperitoneal lymph node size (P = 0.04), the absence of teratoma in the orchiectomy specimen (P = 0.03) and the presence of choriocarcinoma in the testicular analysis after orchiectomy (P = 0.03) were statistically significant predictors of the presence of necrosis. A reduction level of 35% was therefore suggested to be the best cutoff for predicting the absence of tumor in the retroperitoneum with a sensitivity of 73.3% and specificity of 82.4%.

Conclusions

Even though retroperitoneal lymph node dissection remains the gold standard for patients with residual masses, those without teratoma in the primary tumor and a shrinkage of 35% or more in retroperitoneal mass have a considerably smaller chance of having viable GCT or teratoma in the retroperitoneum and a surveillance program could be considered.

Keywords:
Testicular cancer; Retroperitoneal lymph node dissection; Necrosis; Teratoma